Infection of a cell by lentiviruses, such as human immunodeficiency virus type 1 or feline immunodeficiency virus, results in the formation of a reverse transcription complex, the pre-integration complex (PIC), where viral DNA is synthesized. In non-dividing cells, efficient nuclear translocation of the PIC requires the presence of the inner nuclear lamina protein emerin (EMD). Here, we demonstrate that EMD phosphorylation is induced early after infection in primary non-dividing cells. Furthermore, we demonstrate that EMD phosphorylation is dependent on virion-associated mitogen-activated protein kinase (MAPK). Specific inhibition of MAPK activity with kinase inhibitors markedly reduced EMD phosphorylation and resulted in decreased integration of the proviral DNA into chromatin. Similarly, when a MEK1 kinase-inactive mutant was expressed in virus-producer cells, virus-induced phosphorylation of EMD was impaired and viral integration reduced during the subsequent infection. Expression of constitutively active MEK1 kinase in producer cells did not result in modulation of EMD phosphorylation or viral integration during subsequent infection. These studies demonstrate that, in addition to phosphorylating components of the PICs at an early step of infection, virion-associated MAPK plays a role in facilitating cDNA integration after nuclear translocation through phosphorylation of target-cell EMD.

Download full-text PDF

Source
http://dx.doi.org/10.1099/vir.0.019604-0DOI Listing

Publication Analysis

Top Keywords

emd phosphorylation
16
emd
8
immunodeficiency virus
8
non-dividing cells
8
nuclear translocation
8
demonstrate emd
8
viral integration
8
subsequent infection
8
phosphorylation
6
infection
5

Similar Publications

Article Synopsis
  • Lung cancer is a leading cause of cancer deaths worldwide, and this research investigates pCASTOR1 as a potential prognostic marker, focusing on its role in lung adenocarcinoma (LUAD) patients with KRAS mutations.* -
  • The study found that tumor cells have higher pCASTOR1 scores than non-tumor cells, with elevated scores linked to significantly worse overall survival and relapse-free survival, particularly in male patients with KRAS mutations.* -
  • Elevated pCASTOR1 scores could be useful as biomarkers to predict treatment outcomes, suggesting that monitoring these scores may help optimize therapies for male LUAD patients with KRAS mutations.*
View Article and Find Full Text PDF

Extramedullary disease (EMD) is a high-risk feature of multiple myeloma (MM) and remains a poor prognostic factor, even in the era of novel immunotherapies. Here, we applied spatial transcriptomics (RNA tomography for spatially resolved transcriptomics [tomo-seq] [n = 2] and 10x Visium [n = 12]) and single-cell RNA sequencing (n = 3) to a set of 14 EMD biopsies to dissect the 3-dimensional architecture of tumor cells and their microenvironment. Overall, infiltrating immune and stromal cells showed both intrapatient and interpatient variations, with no uniform distribution over the lesion.

View Article and Find Full Text PDF
Article Synopsis
  • - Pemigatinib, a selective FGFR inhibitor, was evaluated in the FIGHT-101 study, which explored its safety and effectiveness in patients with advanced solid tumors, particularly those with FGFR alterations, through various treatment combinations.
  • - Patients received different doses of pemigatinib in combination with drugs like gemcitabine, cisplatin, and pembrolizumab, with key focus on safety, tumor response rates, and pharmacokinetics, resulting in varying levels of treatment-emergent adverse events.
  • - The study showed objective response rates (ORRs) ranging from 0% to 37.5% across different combinations, with some patients experiencing tumor shrinkage, and noted that patients with
View Article and Find Full Text PDF

B cells of people with multiple sclerosis (MS) are more responsive to IFN-γ, corresponding to their brain-homing potential. We studied how a coding single nucleotide polymorphism (SNP) in IFNGR2 (rs9808753) co-operates with Epstein-Barr virus (EBV) infection as MS risk factors to affect the IFN-γ signaling pathway in human B cells. In both cell lines and primary cells, EBV infection positively associated with IFN-γ receptor expression and STAT1 phosphorylation.

View Article and Find Full Text PDF

Chemo-Phosphoproteomic Profiling with ATR Inhibitors Berzosertib and Gartisertib Uncovers New Biomarkers and DNA Damage Response Regulators.

Mol Cell Proteomics

August 2024

MRC Protein Phosphorylation and Ubiquitylation Unit and School of Life Sciences, Wellcome Trust Biocentre, University of Dundee, Dundee, UK. Electronic address:

The ATR kinase protects cells against DNA damage and replication stress and represents a promising anti-cancer drug target. The ATR inhibitors (ATRi) berzosertib and gartisertib are both in clinical trials for the treatment of advanced solid tumors as monotherapy or in combination with genotoxic agents. We carried out quantitative phospho-proteomic screening for ATR biomarkers that are highly sensitive to berzosertib and gartisertib, using an optimized mass spectrometry pipeline.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!